Document is current
Any future updates will be listed below
-
Authors
Koller, Dora https://orcid.org/0000-0002-0415-0466
He, Jun https://orcid.org/0000-0003-4467-7649
Løkhammer, Solveig
Aranda, Selena https://orcid.org/0000-0002-9457-3277
Qiu, Dan
Davtian, David
Chen, Qianyu
Xu, Ziang https://orcid.org/0009-0009-0877-5488
Mao, Zhongzheng https://orcid.org/0009-0001-0800-380X
Friligkou, Eleni https://orcid.org/0009-0003-3682-0991
Karaca, Sefayet
Cormand, Bru https://orcid.org/0000-0001-5318-4382
Flores, Idhaliz
Altmäe, Signe https://orcid.org/0000-0002-0708-1865
Mitjans, Marina
Cabrera-Mendoza, Brenda https://orcid.org/0000-0003-4729-9997
Polimanti, Renato https://orcid.org/0000-0003-0745-6046
-
Funding
Funding for this research was provided by:
Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (RYC2024-050099-I)
Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (JDC2024-055161-I)
Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (PID2021-1277760B-I100)
Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (PID2024-158634OB-I00)
Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (PID2021-12728OB-I00)
Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (PID2022-139740OA-I00)
Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (RYC2021-033573-I)
American Foundation for Suicide Prevention (PDF-0-065-23)
American Foundation for Suicide Prevention (UFA21\100014)
U.S. Department of Health & Human Services | National Institutes of Health (RF1 MH132337)
- License Information
-
More Information
Article History
Received: 23 August 2025
Accepted: 25 March 2026
First Online: 29 April 2026
Competing interests
: R.P. is paid for his editorial work in the journal ‘Complex Psychiatry’ and received a research grant outside the scope of this study from Alkermes. I.F. is the cofounder and co-owner of Sur180 Therapeutics, which is developing a new treatment for endometriosis, and the Chief Scientific Officer of Nura Health, which is developing a noninvasive diagnostic solution for the disease. The other authors declare no competing interests.
